Beyond Air Reports Financial Results for Fiscal Fourth Quarter and Year-End 2020

Reported positive clinical data for third bronchiolitis study using high concentration nitric oxide, achieving primary and key secondary endpointsEnrolled first patient in the U.S. COVID-19 study using the LungFitsystemAnnounced positive pre-clinical data validating high concentration nitric oxide as a potential treatment for ablating solid tumors and inducing an anti-tumor immune responsePMA for the LungFit™ PH to treat persistent pulmonary hypertension of the newborn (PPHN) expected to be submitted to the FDA in the second half of 2020LungFit
Bay Street News

Contact Us

We're not around right now. But you can send us an email and we'll get back to you, asap.

Not readable? Change text. captcha txt

Start typing and press Enter to search